182 related articles for article (PubMed ID: 9705579)
1. Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion.
Ambrosio MR; Campo M; Zatelli MC; Cella SG; Trasforini G; Margutti A; Rigamonti AE; Müller EE; degli Uberti EC
Neuroendocrinology; 1998 Aug; 68(2):123-8. PubMed ID: 9705579
[TBL] [Abstract][Full Text] [Related]
2. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.
degli Uberti EC; Ambrosio MR; Cella SG; Margutti AR; Trasforini G; Rigamonti AE; Petrone E; Müller EE
J Clin Endocrinol Metab; 1997 Sep; 82(9):2885-8. PubMed ID: 9284714
[TBL] [Abstract][Full Text] [Related]
3. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
[TBL] [Abstract][Full Text] [Related]
4. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
Rigamonti AE; Bonomo SM; Cella SG; Müller EE
J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
[TBL] [Abstract][Full Text] [Related]
5. Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation.
Bondanelli M; Ambrosio MR; Margutti A; Boldrini P; Basaglia N; Franceschetti P; Zatelli MC; Degli Uberti EC
Metabolism; 2002 Oct; 51(10):1363-9. PubMed ID: 12370860
[TBL] [Abstract][Full Text] [Related]
6. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
Bondanelli M; Ambrosio MR; Margutti A; Franceschetti P; Zatelli MC; degli Uberti EC
Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
[TBL] [Abstract][Full Text] [Related]
7. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
Arvat E; Maccagno B; Ramunni J; Di Vito L; Gianotti L; Broglio F; Benso A; Deghenghi R; Camanni F; Ghigo E
Neuroendocrinology; 1998 May; 67(5):310-6. PubMed ID: 9641612
[TBL] [Abstract][Full Text] [Related]
8. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
9. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
[TBL] [Abstract][Full Text] [Related]
10. Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans.
Arvat E; Maccagno B; Ramunni J; Giordano R; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
Eur J Endocrinol; 2000 Nov; 143(5):601-6. PubMed ID: 11078983
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
[TBL] [Abstract][Full Text] [Related]
12. The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects.
Stafford PJ; Kopelman PG; Davidson K; McLoughlin L; White A; Rees LH; Besser GM; Coy DH; Grossman A
Clin Endocrinol (Oxf); 1989 Jun; 30(6):661-6. PubMed ID: 2574084
[TBL] [Abstract][Full Text] [Related]
13. Free fatty acids exert an inhibitory effect on adrenocorticotropin and cortisol secretion in humans.
Lanfranco F; Giordano R; Pellegrino M; Gianotti L; Ramunni J; Picu A; Baldi M; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2004 Mar; 89(3):1385-90. PubMed ID: 15001638
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
Arvat E; Maccagno B; Giordano R; Pellegrino M; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.
Arvat E; Ramunni J; Maccagno B; Giordano R; Broglio F; Deghenghi R; Boscaro M; Ghigo E
Neuroendocrinology; 1999 Sep; 70(3):200-6. PubMed ID: 10516483
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
Giordano R; Bo M; Pellegrino M; Vezzari M; Baldi M; Picu A; Balbo M; Bonelli L; Migliaretti G; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2005 Oct; 90(10):5656-62. PubMed ID: 16014406
[TBL] [Abstract][Full Text] [Related]
17. The influence of human corticotropin-releasing hormone on somatostatin secretion in depressed patients and controls.
Lesch KP; Widerlöv E; Ekman R; Laux G; Rupprecht R; Schulte HM; Beckmann H
J Neural Transm; 1989; 75(2):111-8. PubMed ID: 2563752
[TBL] [Abstract][Full Text] [Related]
18. Effects of gender and age on hypothalamic-pituitary-adrenal reactivity after pharmacological challenge with low-dose 1-μg ACTH test: a prospective study in healthy adults.
Lekkakou L; Tzanela M; Lymberi M; Consoulas C; Tsagarakis S; Koutsilieris M
Clin Endocrinol (Oxf); 2013 Nov; 79(5):683-8. PubMed ID: 23480311
[TBL] [Abstract][Full Text] [Related]
19. The pituitary-adrenal glucocorticoid response is altered by gender and disease.
Greenspan SL; Rowe JW; Maitland LA; McAloon-Dyke M; Elahi D
J Gerontol; 1993 May; 48(3):M72-7. PubMed ID: 8387077
[TBL] [Abstract][Full Text] [Related]
20. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
Soule SG; Macfarlane P; Levitt NS; Millar RP
S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
